Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFlowtech Fluid. Regulatory News (FLO)

Share Price Information for Flowtech Fluid. (FLO)

Share Price is delayed by 15 minutes
Get Live Data
61.80    -1.60 (-2.58%)
Bid:
59.00
Ask:
61.80
Spread: 2.80 (4.746%)
Market Cap: £50.33m
FLO Live PriceLast checked at - London Stock Exchange

Intraday Flowtech Fluid. Share Chart

Delisting and Compulsory Acqu

29 Jul 2008 07:00

RNS Number : 0658A
Mentor Graphics Corporation
29 July 2008
Β 

ο»Ώ

Not for release, publication or distribution, in whole or in part, in, into or from theΒ United States,Β Canada,Β AustraliaΒ or any other jurisdiction where to do so would constitute a violation of the relevant laws of such jurisdiction.

FOR IMMEDIATE RELEASE

29Β JULYΒ 2008

REVISED,Β RECOMMENDEDΒ AND MANDATORYΒ CASHΒ OFFER FORΒ FLOMERICSΒ GROUP PLCΒ ("FLOMERICS" OR THE "COMPANY") BYΒ MENTOR GRAPHICS CORPORATIONΒ ("MENTOR")

Delisting

MentorΒ announces thatΒ it has attained in excess of 75 per cent. of the voting rights attaching to Flomerics Shares, andΒ has taken steps to procure theΒ application byΒ FlomericsΒ for theΒ cancellation of the listing of Flomerics Shares on AIM and the cancellation of trading in Flomerics Shares on AIM. It is anticipated that cancellation ofΒ listing and trading will take effect no earlier thanΒ 27Β August 2008.

This follows theΒ announcement on 10 July 2008Β byΒ MentorΒ that all of theΒ conditions of itsΒ RecommendedΒ Offer for the entire issued and to be issuedΒ ordinary share capital ofΒ FlomericsΒ have been satisfied or waived andΒ the Offer is now declared unconditional in all respects.

Following such delisting the liquidity and marketability of any Flomerics Shares that are not acquired byΒ MentorΒ would be significantly reduced. It isΒ Mentor's intention that, after such cancellation, Flomerics will be re-registered as a private company under the relevant provisions of the Companies Act 1985.Β 

Compulsory acquisition of outstandingΒ Flomerics Shares.

MentorΒ alsoΒ announces that by 3.00 pm onΒ 28Β July 2008 it had received valid acceptances in respect of or otherwise contracted to acquireΒ 21,378,423Β Flomerics Shares, representing approximatelyΒ 93.00Β per cent of the Flomerics Shares to which the Offer relates.

Accordingly,Β MentorΒ announces thatΒ compulsory acquisition notices under section 979 of the Companies ActΒ 2006 will be despatchedΒ to the holders of Flomerics Shares who have not yet accepted the Offer. The Offer will remain open for acceptance until further notice. Flomerics Shareholders who have not yet accepted the Offer are reminded to complete and return the Forms of Acceptance as soon as possible.

If you have any queries,Β please contactΒ Computershare onΒ 0870 707Β 1725 or,Β if callingΒ from outside theΒ UK, on +44 870 707Β 1725.

OtherΒ 

Terms defined in the Recommended Offer Document shall, unless the context otherwise requires, haveΒ the same meanings in this announcement.Β The term 'acting in concert' shall have the same meaning as in the City Code.

Enquiries:

Mentor Graphics Corporation
Β 
Ryerson Schwark
Tel: +1 503 685 7000
Β 
Β 
Cenkos Securities plc
Β 
Nicholas Wells
Tel: +44 20 7397 8900
Β 
Β 
Bell Pottinger Corporate & Financial
Β 
David Rydell
Β 
Olly Scott
Tel: +44 20 7861 3232
Β 
Β 
Flomerics Group plc
Β 
Gary Carter
Β 
Keith Butcher
Tel: +44 20 8487 3000
Β 
Β 
Jefferies International Limited
Β 
Andres Pieczanski
Β 
Sarah McNicholas
Tel: +44 20 7029 8000
Β 
Β 
Oriel Securities Limited
Β 
Andrew Edwards
Β 
Michael Shaw
Tel: +44 20 7710 7600
Β 
Β 
Citigate Dewe Rogerson
Β 
Ginny Pulbrook
Β 
Seb Hoyle
Tel: +44 20 7638 9571

Cenkos, which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting exclusively forΒ MentorΒ andΒ no one else in connection with the Offer and will not be responsible to anyone other thanΒ MentorΒ for providing the protections afforded to its customers or for providing advice in relation to the Offer or in relation to the contents of this announcement or any transaction or arrangement referred to herein.

Canaccord,Β which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting exclusively forΒ MentorΒ andΒ no one else in connection with the Offer and will not be responsible to anyone other thanΒ MentorΒ for providing the protections afforded to its customers or for providing advice in relation to the Offer or in relation to the contents of this announcement or any transaction or arrangement referred to herein.

This announcement is not intended to and does not constitute, or form any part of, an offer or an invitation to purchase, subscribe for or otherwise acquire, sell or dispose ofΒ any securities or the solicitation of any vote or approval in any jurisdiction pursuant to the Offer or otherwise.Β Β The OfferΒ isΒ made solely through theΒ RecommendedΒ Offer Document and the Form of Acceptance, which together contain the full terms and conditions of the Offer, including details of how to accept the Offer.Β Β AnyΒ acceptance or other response to the Offer should be made only on the basis of the information contained in theΒ RecommendedΒ Offer Document and the Form of Acceptance.Β Β The laws of relevant jurisdictions may affect the availability of the Offer to persons not resident in theΒ United Kingdom.Β Β Persons who are not resident in theΒ United Kingdom, or who are subject to the laws of any jurisdiction other than theΒ United Kingdom, should inform themselves about and observe any applicable legal and regulatory requirements.Β Β TheΒ RecommendedΒ Offer DocumentΒ isΒ available for public inspectionΒ at the offices of Cenkos.Β 

The OfferΒ isΒ not beingΒ made, directly or indirectly, in or into the United States or by use of mails of, or any means or instrumentality (including, without limitation, facsimile transmission, telephoneΒ or internet) of inter-state or foreign commerce of, or any facilities ofΒ a national, stateΒ or other securities exchange ofΒ the United States, norΒ isΒ it beingΒ made directlyΒ or indirectly in or into CanadaΒ orΒ Australia and the OfferΒ isΒ not capable of acceptance by any such use, means, instrumentality orΒ facilitiesΒ or from within the United States, Canada orΒ Australia or any other such jurisdiction if to do so would constitute a violation of the relevant laws of such jurisdiction.Β Β Accordingly, copies of this announcement are not being, will not be and must not be mailed or otherwise forwarded, distributed or sent in, into orΒ from the United States, Canada orΒ Australia or any other such jurisdiction if to do so would constitute a violation of the relevant laws of such jurisdiction and persons receiving this announcement (including without limitation custodians, nominees and trustees) must not mail,Β or otherwiseΒ forward, distribute or send it in, into or from the United States, CanadaΒ orΒ Australia or any other such jurisdiction if to do so would constitute a violation of the relevant laws of such jurisdiction.

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
CASDDGDRSGDGGII
Date   Source Headline
15th Nov 20217:00 amRNSHolding(s) in Company
10th Nov 20214:09 pmRNSHolding(s) in Company
3rd Nov 20214:41 pmRNSSecond Price Monitoring Extn
3rd Nov 20214:36 pmRNSPrice Monitoring Extension
7th Sep 20217:00 amRNS2021 HALF-YEAR REPORT - six months to 30 June 2021
3rd Aug 20217:00 amRNSGroup Trading Update & Notice of Half-year Results
13th Jul 20215:06 pmRNSHolding(s) in Company
30th Jun 20215:16 pmRNSHolding(s) in Company
3rd Jun 20211:27 pmRNSResult of AGM &Total Voting Rights
1st Jun 20219:49 amRNSImplementation of LTIP and Grant of Options
24th May 20218:36 amRNSHolding(s) in Company - Correction
24th May 20218:36 amRNSClarification of holding in the Company
21st May 20217:00 amRNSHolding(s) in Company -CORRECTION
19th May 20215:40 pmRNSHolding(s) in Company
7th May 20212:11 pmRNSAvailability of the Annual Report & Notice of AGM
6th May 202112:22 pmRNSHolding(s) in Company
22nd Apr 20217:00 amRNSDirector/PDMR Shareholding
20th Apr 20217:00 amRNS2020 Annual Results - Current Trading & Outlook
25th Mar 20217:00 amRNSNotice of Preliminary Results
27th Jan 20212:50 pmRNSHolding(s) in Company
26th Jan 20217:00 amRNS2020 Trading Update
14th Dec 20207:00 amRNSHolding(s) in Company
23rd Nov 20205:18 pmRNSHolding(s) in Company
10th Nov 20204:35 pmRNSPrice Monitoring Extension
5th Nov 20204:41 pmRNSSecond Price Monitoring Extn
5th Nov 20204:36 pmRNSPrice Monitoring Extension
3rd Nov 20204:41 pmRNSSecond Price Monitoring Extn
3rd Nov 20204:36 pmRNSPrice Monitoring Extension
13th Oct 20207:00 amRNSHolding(s) in Company
8th Oct 20202:31 pmRNSHolding(s) in Company
7th Oct 20201:29 pmRNSHolding(s) in Company
24th Sep 20206:03 pmRNSHolding(s) in Company
8th Sep 20207:00 amRNS2020 Half-year Report
13th Aug 20204:41 pmRNSSecond Price Monitoring Extn
13th Aug 20204:36 pmRNSPrice Monitoring Extension
7th Aug 202012:44 pmRNSHolding(s) in Company
28th Jul 20207:00 amRNSGroup Trading Update & Notice of Half-Year Results
6th Jul 20207:00 amRNSHolding(s) in Company
11th Jun 202012:45 pmRNSHolding(s) in Company
11th Jun 20207:00 amRNSResult of AGM and Total Voting Rights (TVR)
10th Jun 20207:00 amRNSAGM Statement
4th Jun 20204:41 pmRNSSecond Price Monitoring Extn
4th Jun 20204:36 pmRNSPrice Monitoring Extension
18th May 20205:44 pmRNSNotice of AGM & Posting of Annual Report
13th May 202012:39 pmRNSHolding(s) in Company
12th May 20207:00 amRNSBoard Changes
11th May 20205:29 pmRNSHolding(s) in Company
7th May 20204:55 pmRNSHolding(s) in Company
30th Apr 20207:00 amRNSAnnual results for the year ended 31 December 2019
21st Apr 20207:00 amRNSQ1 Trading update - Three months ended 31 March

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.